+

CN105483156A - Application of Bac-to-Bac baculovirus expression system to preparation of bombyx mori micro RNA overexpression system - Google Patents

Application of Bac-to-Bac baculovirus expression system to preparation of bombyx mori micro RNA overexpression system Download PDF

Info

Publication number
CN105483156A
CN105483156A CN201610096040.XA CN201610096040A CN105483156A CN 105483156 A CN105483156 A CN 105483156A CN 201610096040 A CN201610096040 A CN 201610096040A CN 105483156 A CN105483156 A CN 105483156A
Authority
CN
China
Prior art keywords
silkworm
microrna
bac
pfastbac1
mir
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610096040.XA
Other languages
Chinese (zh)
Inventor
刘仕平
何婷
尹权�
吴小燕
黄亚玺
王伟
夏庆友
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Southwest University
Original Assignee
Southwest University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Southwest University filed Critical Southwest University
Priority to CN201610096040.XA priority Critical patent/CN105483156A/en
Publication of CN105483156A publication Critical patent/CN105483156A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/14011Baculoviridae
    • C12N2710/14041Use of virus, viral particle or viral elements as a vector
    • C12N2710/14043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

本发明公开了Bac-to-Bac杆状病毒表达系统在制备家蚕microRNA超量表达系统中的应用,家蚕microRNA超量表达系统含有重组pFastBac1载体,重组pFastBac1载体由pFastBac1载体多克隆酶切位点处依次插入红色荧光蛋白编码基因和表达家蚕microRNA的次级前体序列而得,本发明利用Bac-to-Bac杆状病毒表达系统作为家蚕microRNA超量表达系统能够在家蚕细胞和个体水平均实现超量表达家蚕簇microRNAs,为家蚕miRNA的功能研究提供了新的工具。

The invention discloses the application of the Bac-to-Bac baculovirus expression system in the preparation of the silkworm microRNA overexpression system. The silkworm microRNA overexpression system contains a recombinant pFastBac1 vector, and the recombinant pFastBac1 vector is obtained from the multiple cloning enzyme cutting site of the pFastBac1 vector. It is obtained by sequentially inserting the red fluorescent protein coding gene and the secondary precursor sequence expressing silkworm microRNA. The present invention utilizes the Bac-to-Bac baculovirus expression system as the silkworm microRNA overexpression system to realize superexpression at both the silkworm cell and individual levels. Quantitative expression of silkworm cluster microRNAs provides a new tool for the functional study of silkworm miRNAs.

Description

Bac-to-Bac杆状病毒表达系统在制备家蚕microRNA超量表达系统中的应用Application of Bac-to-Bac Baculovirus Expression System in Preparation of Bombyx mori microRNA Overexpression System

技术领域technical field

本发明属于生物技术领域,具体涉及Bac-to-Bac杆状病毒表达系统在制备家蚕microRNA超量表达系统中的应用。The invention belongs to the field of biotechnology, and in particular relates to the application of a Bac-to-Bac baculovirus expression system in preparing a silkworm microRNA overexpression system.

背景技术Background technique

家蚕(silkworm,Bombyxmori)是一种具有重要经济价值和科学研究价值的鳞翅目昆虫。随着家蚕基因组的解析,对家蚕的研究已经进入功能基因组时代。miRNA技术是常用的功能基因研究的技术之一,目前miRNA常用的方法是体外注射人工合成的miRNA模拟物或通过转基因载体来体内高效表达家蚕miRNA,但是体外注射人工合成的miRNA模拟物,成本高、期效短;而通过转基因载体来高效表达家蚕miRNA却又受到表达载体的局限,其原因是目前大多数商业化miRNA表达载体适用于哺乳动物细胞,却不适合于miRNA在昆虫细胞中的表达。The silkworm (Bombyxmori) is a Lepidoptera insect with important economic value and scientific research value. With the analysis of the silkworm genome, the research on silkworm has entered the era of functional genome. miRNA technology is one of the commonly used technologies for functional gene research. At present, the common method of miRNA is to inject artificially synthesized miRNA mimics in vitro or to express silkworm miRNA efficiently in vivo through transgenic vectors, but injecting artificially synthesized miRNA mimics in vitro is costly. , short-term effect; however, the high-efficiency expression of silkworm miRNA through transgenic vectors is limited by the expression vectors. The reason is that most commercial miRNA expression vectors are suitable for mammalian cells, but not suitable for the expression of miRNA in insect cells. .

因此,急需一种适用于家蚕的miRNA表达系统,能够在家蚕个体或细胞中高效表达外源基因,为家蚕miRNA的功能研究提供了新的工具。Therefore, there is an urgent need for a miRNA expression system suitable for silkworms, which can efficiently express foreign genes in silkworm individuals or cells, and provides a new tool for the functional research of silkworm miRNAs.

发明内容Contents of the invention

有鉴于此,本发明的目的之一在于提供Bac-to-Bac杆状病毒表达系统在制备家蚕microRNA超量表达系统中的应用。In view of this, one of the objectives of the present invention is to provide the application of Bac-to-Bac baculovirus expression system in the preparation of Bombyx mori microRNA overexpression system.

为实现上述发明目的,本发明提供如下技术方案:In order to realize the foregoing invention object, the present invention provides following technical scheme:

Bac-to-Bac杆状病毒表达系统在制备家蚕microRNA超量表达系统中的应用。Application of Bac-to-Bac baculovirus expression system in preparation of silkworm microRNA overexpression system.

本发明中,所述家蚕microRNA超量表达系统含有重组pFastBac1载体,所述重组pFastBac1载体由pFastBac1载体多克隆酶切位点处依次插入红色荧光蛋白编码基因和表达家蚕microRNA的次级前体序列而得。In the present invention, the silkworm microRNA overexpression system contains a recombinant pFastBac1 vector, and the recombinant pFastBac1 vector is formed by sequentially inserting a red fluorescent protein encoding gene and a secondary precursor sequence expressing silkworm microRNA at the pFastBac1 vector multiple cloning restriction site. have to.

优选的,所述重组pFastBac1载体由pFastBac1载体的EcoRI和SpeI处插入红色荧光蛋白编码基因,并于XbaI和KpnI酶切位点插入表达家蚕microRNA的次级前体序列而得。Preferably, the recombinant pFastBac1 vector is obtained by inserting the red fluorescent protein coding gene at EcoRI and SpeI of the pFastBac1 vector, and inserting the secondary precursor sequence expressing silkworm microRNA at the XbaI and KpnI restriction sites.

更优选的,所述红色荧光蛋白编码基因的核苷酸序列如SEQIDNO.5所示。More preferably, the nucleotide sequence of the red fluorescent protein encoding gene is shown in SEQ ID NO.5.

更优选的,所述表达家蚕microRNA的次级前体序列的核苷酸序列如SEQIDNO.1、SEQIDNO.2或SEQIDNO.3所示。More preferably, the nucleotide sequence of the secondary precursor sequence expressing silkworm microRNA is shown in SEQ ID NO.1, SEQ ID NO.2 or SEQ ID NO.3.

本发明中,所述重组pFastBac1载体由以下方法制备:克隆红色荧光蛋白编码基因,然后插入pFastBac1载体多克隆酶切位点处,获得重组载体Red-pFastBac1;再克隆表达家蚕microRNA的次级前体序列,然后再插入重组载体Red-pFastBac1的红色荧光蛋白编码基因下游,得家蚕microRNA的超量表达系统。In the present invention, the recombinant pFastBac1 vector is prepared by the following method: cloning the red fluorescent protein coding gene, and then inserting it into the multi-cloning restriction site of the pFastBac1 vector to obtain the recombinant vector Red-pFastBac1; and then cloning the secondary precursor expressing silkworm microRNA sequence, and then inserted into the downstream of the red fluorescent protein coding gene of the recombinant vector Red-pFastBac1 to obtain the overexpression system of silkworm microRNA.

优选的,所述红色荧光蛋白编码基因插入pFastBac1载体的EcoRI和SpeI酶切位点处;所述表达家蚕microRNA的次级前体序列插入pFastBac1载体的XbaI和KpnI酶切位点处。Preferably, the red fluorescent protein encoding gene is inserted into the EcoRI and SpeI restriction sites of the pFastBac1 vector; the secondary precursor sequence expressing the silkworm microRNA is inserted into the XbaI and KpnI restriction sites of the pFastBac1 vector.

本发明的有益效果在于:本发明通过以Bac-to-Bac杆状病毒表达系统作为家蚕microRNA的超量表达系统,该表达系统能够超量表达家蚕簇microRNAs,其中以家蚕let-7簇miRNAs为例,实现了外源基因的高效表达,克服了体外注射人工合成的miRNA模拟物,成本高、期效短的缺陷,同时克服了转基因载体不适合于昆虫细胞的缺陷,并为家蚕miRNA的功能研究提供了新的工具。The beneficial effects of the present invention are: the present invention uses the Bac-to-Bac baculovirus expression system as the overexpression system of silkworm microRNA, and the expression system can overexpress silkworm cluster microRNAs, wherein the silkworm let-7 cluster miRNAs are used as the overexpression system. For example, the high-efficiency expression of exogenous genes has been achieved, and the defects of high cost and short-term effect of injecting artificially synthesized miRNA mimics in vitro have been overcome. At the same time, the defect that transgenic vectors are not suitable for insect cells has been overcome, and the function of silkworm miRNA has been overcome. Research provides new tools.

附图说明Description of drawings

为了使本发明的目的、技术方案和有益效果更加清楚,本发明提供如下附图:In order to make the purpose, technical scheme and beneficial effect of the present invention clearer, the present invention provides the following drawings:

图1为家蚕pri-let-7、pri-miR-100、pri-miR-2795和let-7-CPCR扩增结果(A:pri-let-7扩增结果;B:pri-miR-100扩增结果;C:pri-miR-2795扩增结果;D:let-7-C扩增结果)。Figure 1 shows the amplification results of silkworm pri-let-7, pri-miR-100, pri-miR-2795 and let-7-CPCR (A: amplification result of pri-let-7; B: amplification result of pri-miR-100 Amplification result; C: pri-miR-2795 amplification result; D: let-7-C amplification result).

图2为重组报告基因载体构建(A:Rp-let-7、Rp-miR-100重组质粒和Red-pFastBac1报告基因载体双酶切验证,其中泳道1~5分别表示Rp-let-7重组质粒、Rp-miR-100重组质粒、Rp-let-7重组质粒双酶切、Rp-miR-100重组质粒双酶切、Red-pFastBac1质粒双酶切;B:Rp-miR-2795重组质粒双酶切验证,其中泳道1和2分别表示Rp-miR-2795重组质粒、Rp-miR-2795重组质粒双酶切;C:Rp-let-7-C重组质粒双酶切验证,其中泳道1和2分别表示Rp-let-7-C重组质粒、Rp-let-7-C重组质粒双酶切)。Figure 2 shows the construction of the recombinant reporter gene vector (A: Rp-let-7, Rp-miR-100 recombinant plasmid and Red-pFastBac1 reporter gene vector double enzyme digestion verification, in which lanes 1 to 5 represent the Rp-let-7 recombinant plasmid , Rp-miR-100 recombinant plasmid, Rp-let-7 recombinant plasmid double enzyme digestion, Rp-miR-100 recombinant plasmid double enzyme digestion, Red-pFastBac1 plasmid double enzyme digestion; B: Rp-miR-2795 recombinant plasmid double enzyme Cutting verification, in which lanes 1 and 2 represent Rp-miR-2795 recombinant plasmid, Rp-miR-2795 recombinant plasmid double enzyme digestion; C: Rp-let-7-C recombinant plasmid double restriction digestion verification, in which lanes 1 and 2 Respectively represent Rp-let-7-C recombinant plasmid, Rp-let-7-C recombinant plasmid (double digestion).

图3为miRNA的重组杆状病毒表达载体的构建(A:Red-pFastBac1载体与目的基因连接后载体结构示意图;B:重组后基因结构示意图;C:Rp-let-7重组后PCR检测结果;D:Rp-miR-100E重组后PCR检测结果;F:RP-miR-2795重组后PCR检测结果;A:RP-let-7-C重组后PCR检测结果)。Fig. 3 is the construction of the recombinant baculovirus expression vector of miRNA (A: Red-pFastBac1 carrier and target gene connection after vector structure diagram; B: gene structure diagram after recombination; C: PCR detection result after Rp-let-7 recombination; D: PCR detection results after Rp-miR-100E recombination; F: PCR detection results after RP-miR-2795 recombination; A: PCR detection results after RP-let-7-C recombination).

图4为重组杆状病毒上清液感染Sf9细胞后Red报告基因信号检测(A:未处理的Sf9细胞系(WT);B:阴性对照AcNPV感染Sf9细胞系;C-F:重组杆状病毒Bac-let-7、Bac-miR-100、Bac-miR-2795和Bac-let-7-C上清液分别感染Sf9细胞系(各组左为白光,右为红光))。Figure 4 is the detection of Red reporter gene signal after recombinant baculovirus supernatant infected Sf9 cells (A: untreated Sf9 cell line (WT); B: negative control AcNPV infected Sf9 cell line; C-F: recombinant baculovirus Bac- The supernatants of let-7, Bac-miR-100, Bac-miR-2795 and Bac-let-7-C were infected with Sf9 cell line respectively (the left of each group is white light, the right is red light)).

图5为杆状病毒miRNA表达载体在细胞水平对miRNAs的过量表达。Figure 5 shows the overexpression of miRNAs by the baculovirus miRNA expression vector at the cellular level.

图6为miRNA重组Bacmid在个体水平对miRNAs的过量表达。Figure 6 shows the overexpression of miRNAs by miRNA recombinant Bacmid at the individual level.

具体实施方式detailed description

下面将结合附图,对本发明的优选实施例进行详细的描述。实施例中未注明具体条件的实验方法,通常按照常规条件,例如分子克隆实验指南(第三版,J.萨姆布鲁克等著)中所述的条件,或按照制造厂商所建议的条件。The preferred embodiments of the present invention will be described in detail below with reference to the accompanying drawings. For the experimental methods not specified in the examples, the conventional conditions are generally followed, such as the conditions described in the Molecular Cloning Experiment Guide (Third Edition, J. Sambrook et al.), or the conditions suggested by the manufacturer.

本发明利用杆状病毒载体是一个被广泛应用于真核生物的高效表达外源基因和重组蛋白的工具,将苜蓿银纹夜蛾核型多角体病毒(AcNPV)表达系统超量表达家蚕let-7簇miRNAs,为家蚕miRNA的功能研究提供了新的工具。The present invention uses the baculovirus vector, which is a tool widely used in eukaryotes to efficiently express foreign genes and recombinant proteins, to overexpress the Bombyx mori let- Seven clusters of miRNAs provide a new tool for the functional study of silkworm miRNAs.

实施例1、重组Red-FastBac1报告基因载体的构建Embodiment 1, the construction of recombinant Red-FastBac1 reporter gene carrier

从miRBase(http://www.mirbase.org/)下载家蚕let-7(bmo-let-7)、家蚕miR-100(bmo-miR-100)、家蚕miR-2795(bmo-miR-2795)次级前体序列,具体序列分别如SEQIDNO.1、SEQIDNO.2和SEQIDNO.3所示,然后从家蚕基因组数据库SilkDB(http://silkworm.swu.edu.cn/cgi-bin/gbrowse/silkdb/)中获得家蚕let-7-C(bmo-let-7-C)全长序列,具体序列如SEQIDNO.4所示,从NCBI数据库(http://www.ncbi.nlm.nih.gov/)下载珊瑚虫的Red红色荧光蛋白Red基因序列,具体序列如SEQIDNO.5所示。然后利用primer5.0软件分别设计扩增bmo-let-7、bmo-miR-100、bmo-miR-2795、bmo-let-7-C和Red的引物pri-let-7、pri-miR-100、pri-miR-2795、let-7-C和Red,具体引物如表1所示。Download silkworm let-7 (bmo-let-7), silkworm miR-100 (bmo-miR-100), silkworm miR-2795 (bmo-miR-2795) from miRBase (http://www.mirbase.org/) The secondary precursor sequence, the specific sequence is shown in SEQIDNO.1, SEQIDNO.2 and SEQIDNO.3 respectively, and then from silkworm genome database SilkDB (http://silkworm.swu.edu.cn/cgi-bin/gbrowse/silkdb /) to obtain the full-length sequence of Bombyx mori let-7-C (bmo-let-7-C), the specific sequence is shown in SEQ ID NO.4, from the NCBI database (http://www.ncbi.nlm.nih.gov/ ) to download the Red gene sequence of red fluorescent protein Red of coral polyps, the specific sequence is shown in SEQ ID NO.5. Then use primer5.0 software to design primers pri-let-7, pri-miR-100 for amplifying bmo-let-7, bmo-miR-100, bmo-miR-2795, bmo-let-7-C and Red respectively , pri-miR-2795, let-7-C and Red, the specific primers are shown in Table 1.

表1、pri-let-7、pri-miR-100、pri-miR-2795、let-7-C和Red引物序列Table 1, pri-let-7, pri-miR-100, pri-miR-2795, let-7-C and Red primer sequences

表中序列下划线表示引物中的酶切位点。The underlined sequence in the table indicates the enzyme cleavage site in the primer.

以珊瑚虫cDNA为模板,SEQIDNO.14和SEQIDNO.15为引物进行PCR扩增珊瑚虫Red基因片段,然后用EcoRI和SpeI双酶切Red基因片段,回收Red酶切片段;同时用相同的酶酶切pFastBac1质粒,回收pFastBac1质粒骨架,然后分别取回收的1μLpFastBac1质粒骨架和4μLRed酶切回收片段,用T4连接酶于16℃连接5h,获得重组载体Red-pFastBac1,依次经转化、挑斑、菌液PCR和双酶切验证后,送深圳华大基因测序鉴定。结果表明克隆的珊瑚虫Red基因片段与SEQIDNO.5所示序列一致,表明成功克隆了珊瑚虫Red基因。Use coral polyp cDNA as a template, and use SEQIDNO.14 and SEQIDNO.15 as primers to amplify the coral polyp Red gene fragment by PCR, then use EcoRI and SpeI to double-digest the Red gene fragment, and recover the Red enzyme-digested fragment; at the same time, use the same enzyme to digest pFastBac1 Plasmid, recover the pFastBac1 plasmid backbone, then take the recovered 1 μL pFastBac1 plasmid backbone and 4 μL Red enzyme-digested recovery fragments, and use T4 ligase at 16°C for 5 hours to obtain the recombinant vector Red-pFastBac1, which is transformed, spot-picked, bacterial liquid PCR and After double-enzyme digestion verification, it will be sent to Shenzhen Huada Gene for sequencing identification. The results showed that the cloned polyp Red gene fragment was consistent with the sequence shown in SEQ ID NO.5, indicating that the polyp Red gene was successfully cloned.

以刚化蛾家蚕cDNA为模板,用引物pri-let-7、pri-miR-100、pri-miR-2795和let-7-C分别扩增miRNA初级前体序列bmo-let-7、bmo-miR-100、bmo-miR-2795和bmo-let-7-C;50μL反应体系为10×ExTaqbuffer5μL,dNTPMixture(2.5mM/Leach)4μL,MgCl24μL,引物各1μL,ExTaq(5U/μL)0.5μL,cDNA模板4μL,高压灭菌的双蒸水补至50μL;PCR扩增条件:94℃预变性3min;94℃变性30s,Tm退火30s,72℃延伸时间,共30个循环;最后72℃延伸10min;12℃保存。pri-let-7引物的Tm值为58℃,延伸时间为30s;pri-miR-100引物的Tm值为63℃,延伸时间为30s;pri-miR-2795引物的Tm值为55℃,延伸时间为30s;let-7-C引物的Tm值为59℃,延伸时间为3min;Red的Tm值为63℃,延伸时间为50s。用1%琼脂糖凝胶电泳检测PCR扩增产物,结果如图1所示。然后胶回收目的片段,并连接至pMD19-Tsimple载体,分别获得bmo-let-7-T、bmo-miR-100-T、bmo-miR-2795-T和let-7-C-T质粒,经转化、挑斑、菌液PCR和双酶切验证后送深圳华大基因测序鉴定。Using the cDNA of the rigid moth Bombyx mori as a template, primers pri-let-7, pri-miR-100, pri-miR-2795 and let-7-C were used to amplify the primary miRNA precursor sequences bmo-let-7, bmo- miR-100, bmo-miR-2795 and bmo-let-7-C; 50μL reaction system: 10×ExTaqbuffer 5μL, dNTPMixture (2.5mM/Leach) 4μL, MgCl 2 4μL, each primer 1μL, ExTaq (5U/μL) 0.5 μL, 4 μL of cDNA template, made up to 50 μL with autoclaved double distilled water; PCR amplification conditions: pre-denaturation at 94°C for 3 min; denaturation at 94°C for 30 s, Tm annealing for 30 s, extension time at 72°C, a total of 30 cycles; final 72°C Extend for 10 min; store at 12°C. The Tm value of pri-let-7 primer was 58℃, and the extension time was 30s; the Tm value of pri-miR-100 primer was 63℃, and the extension time was 30s; the Tm value of pri-miR-2795 primer was 55℃, and the extension time The time is 30s; the Tm value of let-7-C primer is 59°C, and the extension time is 3min; the Tm value of Red is 63°C, and the extension time is 50s. The PCR amplification products were detected by 1% agarose gel electrophoresis, and the results are shown in Figure 1. Then the target fragment was recovered by gel and connected to the pMD19-Tsimple vector to obtain bmo-let-7-T, bmo-miR-100-T, bmo-miR-2795-T and let-7-CT plasmids respectively. After transformation, Spot-picking, bacterial liquid PCR and double enzyme digestion were verified and then sent to Shenzhen Huada Genomics for sequencing identification.

用XbaI和KpnI双酶切bmo-let-7-T、bmo-miR-100-T和bmo-miR-2795-T质粒和Red-pFastBac1载体,同时用NotI和XhoI双酶切let-7-C-T质粒和Red-pFastBac1载体,并回收酶切产物(图2)。然后将回收的Red-pFastBac1载体骨架分别与回收的bmo-let-7、bmo-miR-100、bmo-miR-2795和let-7-C片段连接,获得Red-pFastBac1-let-7(简称Rp-let-7)、Red-pFastBac1-miR-100(简称Rp-miR-100)、Red-pFastBac1-miR-2795(简称RP-miR-2795)和Red-pFastBac1-let-7-C(简称RP-let-7-C),载体结构如图3中A所示。Double-digest bmo-let-7-T, bmo-miR-100-T and bmo-miR-2795-T plasmids and Red-pFastBac1 vector with XbaI and KpnI, and double-digest let-7-C-T with NotI and XhoI Plasmids and Red-pFastBac1 vectors, and the digested products were recovered (Figure 2). Then the recovered Red-pFastBac1 vector backbone was connected with recovered bmo-let-7, bmo-miR-100, bmo-miR-2795 and let-7-C fragments respectively to obtain Red-pFastBac1-let-7 (referred to as Rp -let-7), Red-pFastBac1-miR-100 (referred to as Rp-miR-100), Red-pFastBac1-miR-2795 (referred to as RP-miR-2795) and Red-pFastBac1-let-7-C (referred to as RP -let-7-C), the carrier structure is shown in A in Figure 3.

实施例2、重组杆状病毒miRNA过量表达载体构建Embodiment 2, recombinant baculovirus miRNA overexpression vector construction

提取Rp-let-7、Rp-miR-100、RP-miR-2795和RP-let-7-C质粒,转化E.coliDH10Bac/AcNPV感受态细胞(扩大培养本实验室保存的含AcNPV基因组的大肠杆菌,按照网上DH10Bac感受态细胞制备方法步骤制备),取100μL细菌悬液涂布在含7μg·mL-1庆大霉素、10μg·mL-1四环素、50μg·mL-1卡那霉素、40μg·mL-1IPTG和100μg·mL-1X-gal的LB平板培养基上,37℃过夜培养。由于AcNPV上含有pFastBac1载体转座子Tn7整合所需的靶位点mini-attTn7,而E.coliDH10Bac/AcNPV细胞中含有一个能提供Tn7转座蛋白的辅助质粒,使目的基因能更有效地与AcNPV发生重组,重组后基因结构如图3中B所示。并且M13(-40)Forward(简称M13-F)和M13Reverse(简称M13-R)序列分别位于mini-attTn7两端的128bp和145bp处,然后用引物M13-F/R进行菌液PCR,验证各重组杆状病毒DNA,Red-pFastBac1载体上Tn7之间的片段大小为2430bp,再加上目的基因的长度,检测结果分别如图3中C-F所示,可知各miRNA的重组载体Bacmid构建成功,经测序进一步确认。Extract Rp-let-7, Rp-miR-100, RP-miR-2795 and RP-let-7-C plasmids, transform E.coliDH10Bac/AcNPV competent cells (expand the large intestine containing AcNPV genome preserved in our laboratory Bacillus, prepared according to the preparation method of DH10Bac competent cells on the Internet), take 100 μL of bacterial suspension and spread it in the solution containing 7 μg·mL -1 gentamicin, 10 μg·mL -1 tetracycline, 50 μg·mL -1 kanamycin, 40 μg·mL -1 IPTG and 100 μg·mL -1 X-gal on LB plate medium, culture overnight at 37°C. Since AcNPV contains the target site mini-attTn7 required for the integration of pFastBac1 vector transposon Tn7, and E.coliDH10Bac/AcNPV cells contain a helper plasmid that can provide Tn7 transposable protein, so that the target gene can be more effectively integrated with AcNPV Recombination occurs, and the gene structure after recombination is shown in B in FIG. 3 . And the sequences of M13(-40)Forward (M13-F for short) and M13Reverse (M13-R for short) are located at 128bp and 145bp at both ends of mini-attTn7, respectively, and then use primer M13-F/R to carry out bacterial liquid PCR to verify that each recombinant Baculovirus DNA, the size of the fragment between Tn7 on the Red-pFastBac1 vector is 2430bp, plus the length of the target gene, the test results are shown in Fig. further confirm.

实施例3、重组Bacmid转染Sf9细胞系与注射家蚕幼虫Embodiment 3, recombinant Bacmid transfection Sf9 cell line and injection silkworm larvae

以各重组Bacmid(Bac-miRNA)为试验组,非重组空病毒Bacmid(AcNPV)为阴性对照,不加处理的Sf9细胞为空白对照(WT);用8μL的脂质体X-treme包裹1μg的各重组Bacmid,转染Sf9细胞;27℃培养育6-8h后换成完全培养基培养;在96h用OLYMPUS倒置荧光显微镜观察到细胞有较强的红色荧光蛋白信号,通过离心取上清的方式获取有侵染活性的重组Bacmid病毒,分别再去侵染新鲜培养的Sf9细胞,在侵染72h观察到极强烈红色荧光信号,表明病毒已大量增殖(图4),收取第二代重组病毒上清。分别注射5μL第二代各重组病毒上清至家蚕5龄1d幼虫,继续用桑叶饲养5-7d,在5龄7d取整蚕提取总RNA。Each recombinant Bacmid (Bac-miRNA) was used as the test group, non-recombinant empty virus Bacmid (AcNPV) was used as the negative control, and untreated Sf9 cells were used as the blank control (WT); Each recombinant Bacmid was transfected into Sf9 cells; cultured at 27°C for 6-8 hours and then replaced with complete medium; at 96 hours, it was observed that the cells had a strong red fluorescent protein signal with an OLYMPUS inverted fluorescence microscope, and the supernatant was obtained by centrifugation Obtain recombinant Bacmid virus with infective activity, and then infect freshly cultured Sf9 cells. A very strong red fluorescent signal was observed at 72 hours after infection, indicating that the virus had proliferated in large quantities (Figure 4). Collect the second-generation recombinant virus on the clear. Inject 5 μL of the supernatant of each second-generation recombinant virus to the 5th instar 1d larvae of silkworm, and continue to feed them with mulberry leaves for 5-7d, and extract the total RNA from the whole silkworm at 5th instar 7d.

实施例4、重组Bacmid在细胞水平和个体水平miRNAs过量表达Example 4, Recombinant Bacmid Overexpression of miRNAs at Cellular Level and Individual Level

用Trizol提取Sf9细胞和家蚕的总RNA,1.2%琼脂糖凝胶电泳检测RNA质量。利用QIAGEN公司的miScriptSYBRGreenKit定量检测各miRNA,各组设3个生物学重复。qRT-PCR检测发现Bac-let-7、Bac-miR-100、Bac-miR-2795和Bac-let-7-C这4个试验组中的let-7、miR-100和miR-2795均显著过量表达,说明各重组Bacmid在Sf9细胞中都已大量增殖(图5)。在细胞水平,Bac-let-7-C试验组结果显示,簇中各成员即let-7、miR-100和miR-2795均上调表达,这种共表达关系与刘仕平等报道的let-7簇中各成员的表达模式类似,表明克隆的bmo-let-7-C序列中含有各miRNA前体,在Sf9细胞中都能被转录和加工生成相应miRNA成熟体。在家蚕个体水平,qRT-PCR检测结果表明,试验组Bac-let-7、Bac-miR-100和Bac-miR-2795与阴性对照组(AcNPV)相比,let-7、miR-100和miR-2795均显著过量表达(图6中A-C);Bac-let-7-C组中let-7的表达量和阴性对照组AcNPV的相比无明显差异,但和空白对照组let-7的表达量有显著差异(图6中D),Bac-let-7-C组miR-100的表达量与阴性对照组的相比显著过量表达,但与空白对照组的没有明显差异(图6中E),Bac-let-7-C组miR-2795与阴性对照组和空白对照组的相比均为极显著过量表达(图6中F)。然而,在重组病毒感染家蚕后,bmo-let-7、miR-100和miR-2795在个体中均下调表达(图6中A-F),这说明在家蚕个体中由于病毒的大量增殖,导致蚕体内营养大量消耗,破坏了家蚕体内不同器官、组织和细胞的正常代谢环境,使得这些miRNAs的表达受抑制。The total RNA of Sf9 cells and silkworm was extracted with Trizol, and the quality of RNA was detected by 1.2% agarose gel electrophoresis. The miScriptSYBRGreenKit from QIAGEN was used to quantitatively detect each miRNA, and three biological replicates were set up for each group. qRT-PCR detection found that let-7, miR-100 and miR-2795 in the four test groups of Bac-let-7, Bac-miR-100, Bac-miR-2795 and Bac-let-7-C were significantly Overexpression indicated that each recombinant Bacmid had proliferated in Sf9 cells in large quantities (Fig. 5). At the cellular level, the results of the Bac-let-7-C test group showed that each member of the cluster, namely let-7, miR-100 and miR-2795, was up-regulated. This co-expression relationship is consistent with the let-7 The expression patterns of each member in the cluster were similar, indicating that the cloned bmo-let-7-C sequence contained various miRNA precursors, which could be transcribed and processed into corresponding mature miRNAs in Sf9 cells. At the silkworm individual level, the results of qRT-PCR detection showed that compared with the negative control group (AcNPV), Bac-let-7, Bac-miR-100 and Bac-miR-2795 in the experimental group, let-7, miR-100 and miR -2795 was significantly overexpressed (A-C in Figure 6); the expression of let-7 in the Bac-let-7-C group was not significantly different from that of the negative control group AcNPV, but it was different from the expression of let-7 in the blank control group There was a significant difference in the amount of miR-100 (D in Figure 6), and the expression of miR-100 in the Bac-let-7-C group was significantly overexpressed compared with that of the negative control group, but there was no significant difference with that of the blank control group (E in Figure 6 ), miR-2795 in the Bac-let-7-C group was extremely significantly overexpressed compared with the negative control group and the blank control group (Fig. 6, F). However, after the recombinant virus infected the silkworm, the expression of bmo-let-7, miR-100 and miR-2795 were all down-regulated in the individual (Fig. A large amount of nutrients are consumed, which destroys the normal metabolic environment of different organs, tissues and cells in the silkworm, and inhibits the expression of these miRNAs.

因此,本发明构建的miRNA表达载体,能够在家蚕中高效表达外源基因,可用于家蚕miRNA的功能研究提供了新的工具。Therefore, the miRNA expression vector constructed by the present invention can efficiently express exogenous genes in silkworm, and can be used for the functional research of silkworm miRNA to provide a new tool.

最后说明的是,以上优选实施例仅用以说明本发明的技术方案而非限制,尽管通过上述优选实施例已经对本发明进行了详细的描述,但本领域技术人员应当理解,可以在形式上和细节上对其作出各种各样的改变,而不偏离本发明权利要求书所限定的范围。Finally, it should be noted that the above preferred embodiments are only used to illustrate the technical solutions of the present invention and not to limit them. Although the present invention has been described in detail through the above preferred embodiments, those skilled in the art should understand that it can be described in terms of form and Various changes may be made in the details without departing from the scope of the invention defined by the claims.

Claims (7)

  1. The application of 1.Bac-to-Bac baculovirus expression system in preparation silkworm microRNA overexpression system.
  2. 2. application according to claim 1, it is characterized in that: described silkworm microRNA overexpression system contains restructuring pFastBac1 carrier, described restructuring pFastBac1 carrier is cut site by pFastBac1 carrier polyclone enzyme and is inserted red fluorescent protein encoding gene successively and express the secondary precursor sequence of silkworm microRNA and obtain.
  3. 3. application according to claim 1, it is characterized in that: described restructuring pFastBac1 carrier inserts red fluorescent protein encoding gene by EcoRI and SpeI of pFastBac1 carrier, and inserts the secondary precursor sequence of expression silkworm microRNA in XbaI and KpnI restriction enzyme site and obtain.
  4. 4. the application according to Claims 2 or 3, is characterized in that: the nucleotide sequence of described red fluorescent protein encoding gene is as shown in SEQIDNO.5.
  5. 5. the application according to Claims 2 or 3, is characterized in that: the nucleotide sequence of the secondary precursor sequence of described expression silkworm microRNA is as shown in SEQIDNO.1, SEQIDNO.2 or SEQIDNO.3.
  6. 6. the application described in any one of claims 1 to 3, it is characterized in that: described restructuring pFastBac1 carrier is prepared by following methods: clone's red fluorescent protein encoding gene, then insert pFastBac1 carrier polyclone enzyme and cut site, obtain recombinant vectors Red-pFastBac1; The secondary precursor sequence of clonal expression silkworm microRNA again, and then the red fluorescent protein encoding gene downstream of inserting recombinant vectors Red-pFastBac1, obtain the overexpression system of silkworm microRNA.
  7. 7. application according to claim 6, is characterized in that: described red fluorescent protein encoding gene inserts EcoRI and the SpeI restriction enzyme site place of pFastBac1 carrier; The secondary precursor sequence of described expression silkworm microRNA inserts XbaI and the KpnI restriction enzyme site place of pFastBac1 carrier.
CN201610096040.XA 2016-02-22 2016-02-22 Application of Bac-to-Bac baculovirus expression system to preparation of bombyx mori micro RNA overexpression system Pending CN105483156A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610096040.XA CN105483156A (en) 2016-02-22 2016-02-22 Application of Bac-to-Bac baculovirus expression system to preparation of bombyx mori micro RNA overexpression system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610096040.XA CN105483156A (en) 2016-02-22 2016-02-22 Application of Bac-to-Bac baculovirus expression system to preparation of bombyx mori micro RNA overexpression system

Publications (1)

Publication Number Publication Date
CN105483156A true CN105483156A (en) 2016-04-13

Family

ID=55670427

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610096040.XA Pending CN105483156A (en) 2016-02-22 2016-02-22 Application of Bac-to-Bac baculovirus expression system to preparation of bombyx mori micro RNA overexpression system

Country Status (1)

Country Link
CN (1) CN105483156A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106636208A (en) * 2016-11-10 2017-05-10 西南大学 Method of utilizing bombyx mori nuclear polyhedrosis virus vector system to excessively express microRNA

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101787373A (en) * 2009-01-23 2010-07-28 中国人民解放军第二军医大学东方肝胆外科医院 Foreign gene-carrying recombinant virus vector efficiently produced in packaging cell and construction method and application thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101787373A (en) * 2009-01-23 2010-07-28 中国人民解放军第二军医大学东方肝胆外科医院 Foreign gene-carrying recombinant virus vector efficiently produced in packaging cell and construction method and application thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
LI I.-C.等: "登录号:JX088704.1", 《GENBANK》 *
S. LIU等: "MicroRNAs of Bombyx mori identified by Solexa sequencing", 《BMC GENOMICS》 *
何婷等: "利用Bac-to-Bac杆状病毒系统超量表达家蚕 let-7簇microRNAs", 《中国农业科学》 *
佚名: "登录号:NW_004582019.1", 《GENBANK》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106636208A (en) * 2016-11-10 2017-05-10 西南大学 Method of utilizing bombyx mori nuclear polyhedrosis virus vector system to excessively express microRNA

Similar Documents

Publication Publication Date Title
CN107502608B (en) Construction method and application of sgRNA for knocking out human ALDH2 gene and ALDH2 gene deletion cell line
CN104805099B (en) A kind of nucleic acid molecules and its expression vector of safe coding Cas9 albumen
EP3461894A1 (en) Engineered crispr-cas9 compositions and methods of use
Siniscalchi et al. Human MicroRNAs interacting with SARS-CoV-2 RNA sequences: computational analysis and experimental target validation
HK1247238A1 (en) Engineered crispr-cas9 compositions and methods of use
Katsuma et al. Transcriptome profiling reveals infection strategy of an insect maculavirus
EP2925866A1 (en) Circular rna for inhibition of microrna
WO2019227640A1 (en) Reagent and method for repairing fbn1t7498c mutation using base editing
CN113308553B (en) circRNA related to development of sheep skeletal muscle and application thereof
WO2024199396A1 (en) Cas13 protein, and crispr-cas system and use thereof
CN103710387B (en) A kind of method promoting bovine muscle satellite cell in-vitro multiplication
CN105861551A (en) Vector for jointly expressing MicroRNAs to inhibit breast cancer cell proliferation and construction method and application thereof
CN102296069B (en) Untranslated region-specific artificial microRNAs that effectively inhibit the replication of different strains of porcine reproductive and respiratory syndrome virus
CN114836418B (en) CRISPR-Cas13d system for knocking down porcine epidemic diarrhea virus
CN110229816B (en) Construction method and application of sgRNA for knocking out RBP4 gene, RBP4 gene deletion cell line
CN105483156A (en) Application of Bac-to-Bac baculovirus expression system to preparation of bombyx mori micro RNA overexpression system
Ryan et al. Mapping the Pax6 3’untranslated region microRNA regulatory landscape
CN101402945A (en) Process for producing small RNA recombinant birds adeno-associated virus for expression of infectivity resistant bursa of fabricius disease virus
CN109628447B (en) sgRNA specifically targeting sheep-friendly site H11 and its coding DNA and application
CN103710372B (en) A kind of construction process of the miR-505 high-expression vector for functional study
CN102260672A (en) siRNA (small interfering RNA) for inhibiting expression of porcine Somatostatin receptor 2
CN104195153B (en) A kind of Bicistronic mRNA coexpression gene transporter and preparation method
CN115491377B (en) Nucleotide sequence for inducing RNA interference and reducing and eliminating virus pollution in cells and application thereof
Huang et al. Construction of baculovirus expression vector of miRNAs and its expression in insect cells
Kotagama Mechanisms of MiRNA-based Gene Regulation in C. Elegans and Human Cells

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20160413

RJ01 Rejection of invention patent application after publication
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载